Table 2.
Up-regulated expression of LOX in tumor tissues
Cancer type | Results | Function | References |
---|---|---|---|
Breast cancer |
10-year DMSFa low 10-year OSb low |
Activate HIF1-Akt pathway; mediate hypoxic control of metastasis; regulate actin filament formation; contribute to mechanotransduction-mediated regulation of TGF-β signaling; recruit BMDCs to form the pre-metastatic niche | [29, 34, 36] |
Colorectal cancer | / | Correlated with absence of lymphovascular invasion; activate PI3K–Akt pathway to up-regulate HIF-1α protein synthesis | [37, 38] |
Head and neck squamous cell carcinoma | 5-year OSc low | Strongly associated with increased metastasis, progression and death | [39] |
Lung adenocarcinoma | 5-year OS low | ECM remodeling; associated with advanced stage and metastasis | [40, 41] |
Oral and oropharyngeal squamous cell carcinoma | 10-year OS low | Independent prognostic biomarker and predictor of lymph node metastasis | [42] |
a10-year DMSF: 10-year distant metastasis free survival
b10-year OS low: 10-year overall survival
c5-year OS low: 5-year overall survival